{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:45:28Z","timestamp":1772927128383,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Portuguese Foundation for Science and Technology","award":["UID\/04501\/2025"],"award-info":[{"award-number":["UID\/04501\/2025"]}]},{"name":"Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","award":["CI-IPOP-134-2020"],"award-info":[{"award-number":["CI-IPOP-134-2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Head and neck squamous cell carcinoma (HNSCC) is a major clinical challenge due to its aggressive nature and poor prognosis in advanced stages. Late detection, often due to a delayed diagnosis, limits treatment success. With the aim of improving the early diagnosis of HNSCC, we analysed urine samples from 19 male HNSCC patients and 10 healthy male subjects and identified 1427 proteins by mass spectrometry (MS)-based proteomics. Of these, 351 proteins were consistently detected in all subjects and selected for quantitative comparisons, which highlighted potential prognostic markers such as RNASE1, LRG1, and CD44. Proteogenomic cross-referencing of MS-identified peptides with cancer variant databases suggested the presence of HNSCC-associated protein variants [e.g. GAA p.(Trp746Cys) and SIAE p.(Pro210Leu)] as potential indicators of advanced disease. Functional analyses linked the identified proteins to important tumour-related processes, including the epithelial\u2212mesenchymal transition and neutrophil degranulation. These results support urine as a valuable body fluid for proteogenomic profiling, as it can be collected non-invasively, is available in large volumes, and enables the longitudinal monitoring of molecular changes over time, providing a convenient window into systemic and tumour-associated processes. This study provides a proof of concept that tumour-related protein variants originating from HNSCC can be detected in urine, supporting its potential as a source of biomarkers for early detection. However, given the small, male-only cohort, these findings should be regarded as preliminary and will require validation in larger, sex-balanced cohorts, including patients with benign or inflammatory head and neck conditions, to confirm disease specificity. Altogether, our data underscore the translational promise of urinary proteogenomics in HNSCC management.<\/jats:p>","DOI":"10.1093\/molecular-omics\/aaiag002","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:54:29Z","timestamp":1770382469000},"source":"Crossref","is-referenced-by-count":0,"title":["Uncovering urinary proteogenomic signatures associated with head and neck squamous cell carcinoma"],"prefix":"10.1093","volume":"22","author":[{"given":"Oriana","family":"Barros","sequence":"first","affiliation":[{"name":"iBiMED, Department of Medical Sciences, University of Aveiro , Aveiro ,","place":["Portugal"]},{"name":"Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology , Porto ,","place":["Portugal"]},{"name":"Department of Cellular, Computational and Integrative Biology, University of Trento , Trento ,","place":["Italy"]}]},{"given":"Joaquim Castro","family":"Silva","sequence":"additional","affiliation":[{"name":"Otorhinolaringology Service, Portuguese Institute for Oncology , Porto ,","place":["Portugal"]}]},{"given":"Eurico","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Otorhinolaringology Service, Portuguese Institute for Oncology , Porto ,","place":["Portugal"]},{"name":"School of Medicine and Biomedical Sciences, University of Fernando Pessoa , Porto ,","place":["Portugal"]}]},{"given":"Susana","family":"Aveiro","sequence":"additional","affiliation":[{"name":"LAQV-REQUIMTE, Department of Chemistry, University of Aveiro , Aveiro ,","place":["Portugal"]}]},{"given":"Pedro","family":"Domingues","sequence":"additional","affiliation":[{"name":"LAQV-REQUIMTE, Department of Chemistry, University of Aveiro , Aveiro ,","place":["Portugal"]}]},{"given":"Pedro Valente","family":"Sousa","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology , Porto ,","place":["Portugal"]}]},{"given":"Carolina","family":"Castro","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology , Porto ,","place":["Portugal"]}]},{"given":"Catarina","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology , Porto ,","place":["Portugal"]}]},{"given":"Ant\u00f3nio","family":"Barros","sequence":"additional","affiliation":[{"name":"RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]}]},{"given":"Francisco","family":"Amado","sequence":"additional","affiliation":[{"name":"iBiMED, Department of Medical Sciences, University of Aveiro , Aveiro ,","place":["Portugal"]},{"name":"LAQV-REQUIMTE, Department of Chemistry, University of Aveiro , Aveiro ,","place":["Portugal"]}]},{"given":"Saeid","family":"Ghavami","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Academy of Silesia , 40-555 Katowice ,","place":["Poland"]},{"name":"Paul Albrechtsen Research Institute, Cancer Care Manitoba , Winnipeg, MB R3E 0V9 ,","place":["Canada"]},{"name":"Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba , Winnipeg, MB R3E 0V9 ,","place":["Canada"]}]},{"given":"Vito G","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Department of Cellular, Computational and Integrative Biology, University of Trento , Trento ,","place":["Italy"]}]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[{"name":"LAQV-REQUIMTE, Department of Chemistry, University of Aveiro , Aveiro ,","place":["Portugal"]}]},{"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[{"name":"iBiMED, Department of Medical Sciences, University of Aveiro , Aveiro ,","place":["Portugal"]},{"name":"RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]}]},{"given":"L\u00facio Lara","family":"Santos","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology , Porto ,","place":["Portugal"]},{"name":"Surgical Oncology Department, Portuguese Institute for Oncology , Porto ,","place":["Portugal"]}]}],"member":"286","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2026030623015961600_ref1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"2026030623015961600_ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194967","article-title":"Challenges in the early diagnosis of oral cancer, evidence gaps and strategies for improvement: a scoping review of systematic reviews","volume":"14","author":"Gonz\u00e1lez-Moles","year":"2022","journal-title":"Cancers"},{"key":"2026030623015961600_ref3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","article-title":"The FDA NIH biomarkers, endpoints, and other tools (BEST) resource in neuro-oncology","volume":"20","author":"Cagney","year":"2018","journal-title":"Neuro-Oncology"},{"key":"2026030623015961600_ref4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer: current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026030623015961600_ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051579","article-title":"Liquid biopsies, novel approaches and future directions","volume":"15","author":"Armakolas","year":"2023","journal-title":"Cancers"},{"key":"2026030623015961600_ref6","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.3390\/cancers16183129","article-title":"The role of ctDNA and liquid biopsy in the diagnosis and monitoring of head and neck cancer: towards precision medicine","volume":"16","author":"Nassar","year":"2024","journal-title":"Cancers"},{"key":"2026030623015961600_ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112652","article-title":"Urine as a source of liquid biopsy for cancer","volume":"13","author":"Oshi","year":"2021","journal-title":"Cancers"},{"key":"2026030623015961600_ref8","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hed.28138","article-title":"Emerging proximal liquid biopsy approaches for detecting residual disease and predicting recurrence in head and neck cancer: a review and proposal of novel liquid staging","volume":"47","author":"Helou","year":"2025","journal-title":"Head Neck"},{"key":"2026030623015961600_ref9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.urine.2023.10.001","article-title":"Urine biomarkers can outperform serum biomarkers in certain diseases","volume":"5","author":"Xue","year":"2023","journal-title":"Urine"},{"key":"2026030623015961600_ref10","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1002\/ctd2.183","article-title":"Recent development of urinary biomarkers for bladder cancer diagnosis and monitoring","volume":"3","author":"Zeng","year":"2023","journal-title":"Clin Transl Discov"},{"key":"2026030623015961600_ref11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24040794","article-title":"Urinary proteomics profiles are useful for detection of cancer biomarkers and changes induced by therapeutic procedures","volume":"24","author":"Ferrari","year":"2019","journal-title":"Molecules"},{"key":"2026030623015961600_ref12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41698-025-00856-2","article-title":"Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma","volume":"9","author":"Ourailidis","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"2026030623015961600_ref13","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1038\/s41467-025-63538-4","article-title":"Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Nat Commun"},{"key":"2026030623015961600_ref14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s10157-025-02639-2","article-title":"Age and gender differences in the urinary proteome of healthy subjects using the advantages of quantitative proteomics","volume":"29","author":"Yamamoto","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"2026030623015961600_ref15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12014-018-9220-2","article-title":"Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer","volume":"15","author":"Lin","year":"2018","journal-title":"Clin Proteomics"},{"key":"2026030623015961600_ref16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"2026030623015961600_ref17","doi-asserted-by":"publisher","first-page":"104190","DOI":"10.1016\/j.isci.2022.104190","article-title":"ToPP: tumor online prognostic analysis platform for prognostic feature selection and clinical patient subgroup selection","volume":"25","author":"Ouyang","year":"2022","journal-title":"iScience"},{"key":"2026030623015961600_ref18","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"2026030623015961600_ref19","doi-asserted-by":"publisher","first-page":"D1246","DOI":"10.1093\/nar\/gkad1060","article-title":"DriverDBv4: a multi-omics integration database for cancer driver gene research","volume":"52","author":"Liu","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026030623015961600_ref20","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026030623015961600_ref21","doi-asserted-by":"publisher","first-page":"D684","DOI":"10.1093\/nar\/gkm795","article-title":"STITCH: interaction networks of chemicals and proteins","volume":"36","author":"Kuhn","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2026030623015961600_ref22","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.7150\/thno.67409","article-title":"Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion","volume":"12","author":"Gaiteiro","year":"2022","journal-title":"Theranostics"},{"key":"2026030623015961600_ref23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1620\/tjem.232.9","article-title":"CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis","volume":"232","author":"Chai","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"2026030623015961600_ref24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2407-14-15","article-title":"Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Cancer"},{"key":"2026030623015961600_ref25","doi-asserted-by":"publisher","first-page":"152213","DOI":"10.1016\/j.anndiagpath.2023.152213","article-title":"Prognostic value of CD44 expression in oral squamous cell carcinoma: a meta-analysis","volume":"67","author":"Mirhashemi","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"2026030623015961600_ref26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12920-025-02103-w","article-title":"Comprehensive pan-cancer analysis of HSPG2 as a marker for prognosis","volume":"18","author":"Chen","year":"2025","journal-title":"BMC Med Genet"},{"key":"2026030623015961600_ref27","doi-asserted-by":"publisher","first-page":"36099","DOI":"10.18632\/oncotarget.16432","article-title":"Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder","volume":"8","author":"Miyake","year":"2017","journal-title":"Oncotarget"},{"key":"2026030623015961600_ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00397","article-title":"Tumor microenvironment: extracellular matrix alterations influence tumor progression","volume":"10","author":"Brassart-Pasco","year":"2020","journal-title":"Front Oncol"},{"key":"2026030623015961600_ref29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","article-title":"Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology","volume":"38","author":"Nissen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"2026030623015961600_ref30","doi-asserted-by":"publisher","DOI":"10.3390\/genes9110556","article-title":"Modular proteoglycan Perlecan\/HSPG2: mutations, phenotypes, and functions","volume":"9","author":"Martinez","year":"2018","journal-title":"Genes"},{"key":"2026030623015961600_ref31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.matbio.2013.08.004","article-title":"Border patrol: insights into the unique role of perlecan\/heparan sulfate proteoglycan 2 at cell and tissue borders","volume":"34","author":"Farach-Carson","year":"2014","journal-title":"Matrix Biol: J Int Soc Matrix Biol"},{"key":"2026030623015961600_ref32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-0714.2004.00026.x","article-title":"Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium","volume":"33","author":"Ikarashi","year":"2004","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"2026030623015961600_ref33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/jop.12184","article-title":"Three-dimensional visualization of perlecan-rich neoplastic stroma induced concurrently with the invasion of oral squamous cell carcinoma","volume":"43","author":"Maruyama","year":"2014","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"2026030623015961600_ref34","doi-asserted-by":"publisher","first-page":"e115004","DOI":"10.1371\/journal.pone.0115004","article-title":"Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma","volume":"9","author":"Kawahara","year":"2014","journal-title":"PLoS One"},{"key":"2026030623015961600_ref35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12032-022-01746-4","article-title":"Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through \u03b2-catenin signaling in oral squamous cell carcinoma","volume":"39","author":"Guo","year":"2022","journal-title":"Med Oncol"},{"key":"2026030623015961600_ref36","doi-asserted-by":"publisher","DOI":"10.3390\/genes12060872","article-title":"Utility of EFEMP1 in the prediction of oncologic outcomes of urothelial carcinoma","volume":"12","author":"Chen","year":"2021","journal-title":"Genes"},{"key":"2026030623015961600_ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1014749","article-title":"The extracellular matrix protein fibulin-3\/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K\/Akt signaling","volume":"12","author":"Roshini","year":"2022","journal-title":"Front Oncol"},{"key":"2026030623015961600_ref38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/gim.2013.187","article-title":"Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes","volume":"16","author":"Shirts","year":"2014","journal-title":"Genet Med"},{"key":"2026030623015961600_ref39","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2026030623015961600_ref40","doi-asserted-by":"publisher","first-page":"S989","DOI":"10.4103\/jpbs.jpbs_380_21","article-title":"Assessment of serum selenium and ceruloplasmin in potentially malignant disorders and oral cancer","volume":"13","author":"Mampilly","year":"2021","journal-title":"J Pharm Bioallied Sci"},{"key":"2026030623015961600_ref41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/jcar.jcar_10_21","article-title":"Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers","volume":"20","author":"Patil","year":"2021","journal-title":"J Carcinog"},{"key":"2026030623015961600_ref42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/jso.20818","article-title":"Alleviation of oxidative and nitrosative stress following curative resection in patient with oral cavity cancer","volume":"96","author":"Rasheed","year":"2007","journal-title":"J Surg Oncol"},{"key":"2026030623015961600_ref43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1385\/bter:91:1:11","article-title":"Trace elements and some extracellular antioxidant protein levels in serum of patients with laryngeal cancer","volume":"91","author":"Taysi","year":"2003","journal-title":"Biol Trace Elem Res"},{"key":"2026030623015961600_ref44","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/odi.12690","article-title":"Determination of role of ceruloplasmin in oral potentially malignant disorders and oral malignancy-a cross-sectional study","volume":"23","author":"Shah","year":"2017","journal-title":"Oral Dis"},{"key":"2026030623015961600_ref45","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/glycob\/cwv034","article-title":"Human sialic acid acetyl esterase: towards a better understanding of a puzzling enzyme","volume":"25","author":"Orizio","year":"2015","journal-title":"Glycobiology"},{"key":"2026030623015961600_ref46","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1038\/ncomms8673","article-title":"9-O-acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate","volume":"6","author":"Baumann","year":"2015","journal-title":"Nat Commun"},{"key":"2026030623015961600_ref47","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/glycob\/cwab068","article-title":"Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway","volume":"31","author":"Grabenstein","year":"2021","journal-title":"Glycobiology"},{"key":"2026030623015961600_ref48","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.it.2009.07.006","article-title":"Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance","volume":"30","author":"Pillai","year":"2009","journal-title":"Trends Immunol"},{"key":"2026030623015961600_ref49","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.oooo.2013.01.004","article-title":"Evaluation of serum and salivary total sialic acid and \u03b1-l-fucosidase in patients with oral precancerous conditions and oral cancer","volume":"115","author":"Vajaria","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2026030623015961600_ref50","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/cas.14921","article-title":"Suppression of lysosomal acid alpha-glucosidase impacts the modulation of transcription factor EB translocation in pancreatic cancer","volume":"112","author":"Hamura","year":"2021","journal-title":"Cancer Sci"}],"container-title":["Molecular Omics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/advance-article-pdf\/doi\/10.1093\/molecular-omics\/aaiag002\/66798632\/aaiag002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/2\/aaiag002\/66798632\/aaiag002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/2\/aaiag002\/66798632\/aaiag002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:02:03Z","timestamp":1772856123000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/doi\/10.1093\/molecular-omics\/aaiag002\/8466332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,6]]}},"URL":"https:\/\/doi.org\/10.1093\/molecular-omics\/aaiag002","relation":{},"ISSN":["2515-4184"],"issn-type":[{"value":"2515-4184","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,6]]},"article-number":"aaiag002"}}